GlassScriptPhysician profile
Steven P Rider
NPI 1730159534
$11,369.55
in general payments reported to CMS, 2019-2025
79 companies · $1,332 in 2025
The $1,332 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,224 · 2020: $1,240 · 2021: $1,740 · 2022: $1,444 · 2023: $1,112 · 2024: $2,276 · 2025: $1,332.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,721.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,720.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $1,275.37 | 2019-2025 | Briviact, Nayzilam, Fintepla |
| Abbvie INC. | $772.20 | 2019-2025 | |
| Alexion Pharmaceuticals, INC. | $569.95 | 2019-2025 | Ultomiris, Soliris |
| Csl Behring | $516.89 | 2019-2025 | Hizentra |
| Novartis Pharmaceuticals Corporation | $456.86 | 2019-2024 | |
| Neurelis, INC. | $424.89 | 2020-2025 | Valtoco |
| Biogen, INC. | $407.10 | 2019-2025 | Vumerity, Tysabri, Skyclarys |
| Genzyme Corporation | $402.73 | 2019-2025 | |
| Allergan, INC. | $395.49 | 2019-2022 | |
| Supernus Pharmaceuticals, INC. | $347.37 | 2019-2020 | |
| Eisai INC. | $255.70 | 2019-2024 | |
| Emd Serono, INC. | $235.52 | 2019-2025 | Mavenclad |
| Greenwich Biosciences, INC. | $215.26 | 2019-2021 | |
| Lundbeck LLC | $201.01 | 2019-2025 | Vyepti |
| Biohaven Pharmaceuticals, INC. | $198.20 | 2020-2021 |
Show all 79 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Rider listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.